ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colonic Cancer
Colorectal Cancer
Rectal Cancer
Non-Small-Cell Lung Carcinoma
Pancreatic Cancer
Cancer
Neoplasm Metastasis

Colon Cancer trials near Louisville, KY, USA:

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...

Enrolling
Colonic Neoplasms
Neoplasms, Colon
Drug: CAPEOX
Biological: Dostarlimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Louisville, Kentucky, United States and 262 other locations

The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with re...

Enrolling
Clear Cell Renal Cell Carcinoma
Biological: XmAb819

Phase 1

Xencor
Xencor

Louisville, Kentucky, United States and 26 other locations

the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon...

Enrolling
Stage III Colon Cancer
Drug: mFOLFOX6 3-6 month
Device: Signatera test

Phase 2, Phase 3

NRG Oncology
NRG Oncology

Louisville, Kentucky, United States and 1076 other locations

The goal of this clinical trial is to determine the safety and efficacy of IP-001 for intratumoral injection administration following thermal ablatio...

Active, not recruiting
Nonsmall Cell Lung Cancer
Colon Cancer
Drug: 1.0% IP-001 for Injection

Phase 1, Phase 2

Immunophotonics

Louisville, Kentucky, United States and 15 other locations

The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon...

Enrolling
Colonic Diseases
Intestinal Neoplasms
Biological: Bevacizumab
Drug: Chemotherapy

Phase 3

Pfizer
Pfizer

Louisville, Kentucky, United States and 307 other locations

a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon...

Active, not recruiting
Colorectal Neoplasms
Drug: Eflornithine placebo & sulindac placebo
Drug: Eflornithine plus sulindac

Phase 3

SWOG Cancer Research Network
SWOG Cancer Research Network

Louisville, Kentucky, United States and 990 other locations

The primary objective of the Phase 2 portion of the study is to characterize the clinical activity of maintenance therapy with GRT-C901/GRT-R902 (pat...

Active, not recruiting
Colorectal Neoplasms
Drug: Ipilimumab
Drug: Atezolizumab

Phase 2, Phase 3

Seattle Project Corporation

Louisville, Kentucky, United States and 42 other locations

Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene ...

Enrolling
Colon Adenocarcinoma
Rectal Adenocarcinoma
Drug: Leucovorin/levofolinate calcium
Drug: 5-Fluorouracil

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Louisville, Kentucky, United States and 237 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems